The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

The Central Drug Standards Control Organization (CDSCO) has granted a license to Biolumpivaxin, India’s first vaccine against ...

Be it from tap water on a vacation, some dodgy chicken, or something the kids have brought home from school, we've almost all ...

Biovet, a subsidiary of the Bharat Biotech Group, has received approval from the CDSCO for its innovative LSD vaccine, ...

In the last two years, around 200,000 cattle have died, millions lost their milk production capabilities due to LSD ...

Hyderabad: Biovet, an arm of the Bharat Biotech group that makes animal health vaccines, received a licence from the Central ...

Biovet receives CDSCO license for LSD vaccine, a game-changer for animal health, developed in collaboration with ICAR.

Biovet has secured a license from CDSCO for Biolumpivaxin, the world's only marker vaccine for Lumpy Skin Disease in cattle ...

The development of bacterial vaccines has played a critical role in combating infectious diseases, significantly reducing mortality and morbidity worldwide.

A study was conducted to assess the safety and tolerability of the tetravalent live-attenuated dengue vaccine Qdenga®, which received marketing approval in Germany in 2022. The study evaluated vaccine ...

Attenuated Vaccines MarketThe global attenuated vaccines market is set for significant expansion, with sales projected to ...

Bharat Biotech Group has announced its Lumpy Skin Disease (LSD) vaccine for dairy cattle and buffaloes, BIOLUMPIVAXIN has ...